An Optimized Protocol for Simultaneous Propagation of Patient-derived Organoids and Matching CAFs
Recurrent hormone receptor-positive (HR+) breast cancer is a leading cause of cancer mortality in women. Recurrence and resistance to targeted therapies have been difficult to study due to the long clinical course of the disease, the complex nature of resistance, and the lack of clinically relevant...
Saved in:
Main Authors: | Jenny Högström, Taru Muranen |
---|---|
Format: | Article |
Language: | English |
Published: |
Bio-protocol LLC
2025-01-01
|
Series: | Bio-Protocol |
Online Access: | https://bio-protocol.org/en/bpdetail?id=5160&type=0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the potential: Patient-derived organoids in cancer research and treatment
by: Zhan Wang
Published: (2024-03-01) -
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
by: Ann-Kathrin Lederer, et al.
Published: (2025-01-01) -
Cost-reduction strategy to culture patient derived bladder tumor organoids
by: Mahsa Mollapour Sisakht, et al.
Published: (2025-02-01) -
Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysis
by: Mattijs Bulcaen, et al.
Published: (2025-03-01) -
Gene Editing in Pluripotent Stem Cells and Their Derived Organoids
by: Hang Zhou, et al.
Published: (2021-01-01)